FDA
-
-
-
-
-
-
-
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
-
-
-
-
-
-
-
National Institutes of Health Awards Grant for Pivotal Clinical Trial of gammaCore™ (nVNS) in Patients with Opioid Use Disorders
-
-
-
-
-
-
-
electroCore, Inc. Announces Exclusive Distribution Agreement with Byond Healthcare Pty Ltd, South Africa
-
-
-
-
-
-
-
electroCore and Joerns Healthcare Partner to Expand Use Of gammaCore™ Vagus Nerve Technology for Headache Sufferers
-
-
-
-
-
-
-
electroCore Provides Select Third Quarter 2022 Financial Guidance
-
-
-
-
-
-
-
electroCore Announces Record Second Quarter 2022 Financial Results
-
-
-
-
-
-
-
electroCore Announces Publication of Investigator-Initiated Trial Data for SAVIOR-1 in COVID-19 Patients in Frontiers in Neurology
-
327,753 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

